======= GCSH ======= == Gene Information == * **Official Symbol**: GCSH * **Official Name**: glycine cleavage system protein H * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2653|2653]] * **UniProt**: [[https://www.uniprot.org/uniprot/P23434|P23434]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GCSH&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GCSH|Open PubMed]] * **OMIM**: [[https://omim.org/entry/238330|Open OMIM]] == Function Summary == * **Entrez Summary**: Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the H protein, which transfers the methylamine group of glycine from the P protein to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH). Two transcript variants, one protein-coding and the other probably not protein-coding,have been found for this gene. Also, several transcribed and non-transcribed pseudogenes of this gene exist throughout the genome.[provided by RefSeq, Jan 2010]. * **UniProt Summary**: The glycine cleavage system catalyzes the degradation of glycine. The H protein (GCSH) shuttles the methylamine group of glycine from the P protein (GLDC) to the T protein (GCST). {ECO:0000269|PubMed:1671321}. |GCV H| |glycine cleavage complex| |aminomethyltransferase activity| |glycine catabolic process| |glycine decarboxylation via glycine cleavage system| |protein lipoylation| |protein-cofactor linkage| |serine family amino acid catabolic process| |glycine metabolic process| |neurotransmitter catabolic process| |serine family amino acid metabolic process| |neurotransmitter metabolic process| |alpha-amino acid catabolic process| |cellular amino acid catabolic process| |drug catabolic process| |alpha-amino acid metabolic process| |protein maturation| |organic acid catabolic process| |carboxylic acid catabolic process| |cellular amino acid metabolic process| |methylation| |peptidyl-lysine modification| |regulation of neurotransmitter levels| |mitochondrial matrix| |small molecule catabolic process| |drug metabolic process| |peptidyl-amino acid modification| |carboxylic acid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |organonitrogen compound catabolic process| |mitochondrion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |gene expression| \\ === CRISPR Data === No hits were found. ^Gene^Correlation^ |[[:human genes:l:lipt2|LIPT2]]|0.508| |[[:human genes:l:lipt1|LIPT1]]|0.498| |[[:human genes:l:lias|LIAS]]|0.425| |[[:human genes:s:suclg1|SUCLG1]]|0.409| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1880 * **Expression level (log2 read counts)**: 5.52 {{:chemogenomics:nalm6 dist.png?nolink |}}